Home
/

What is an Eosinophils Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

Eosinophils are specialized white blood cells that mature in bone marrow under IL-5 and migrate to barrier tissues (gut, lungs, skin) to fight parasites and drive allergic inflammation through toxic granule proteins and Th2 cytokines. Normally comprising only a small single-digit percentage of white cells, elevated counts are associated with allergic conditions (asthma, eczema), parasitic infections, or drug reactions, while very high persistent levels may help identify hypereosinophilic syndrome with potential organ damage.

Read more →
Table of contents

Eosinophils as a window into type 2 immunity

Eosinophils are a specialized type of white blood cell (granulocytic leukocytes) made in the bone marrow. After maturing, they pass through the bloodstream briefly before settling in tissues, especially the gut, lungs, and skin. An eosinophil blood test measures how many of these cells are circulating at a given moment. Because eosinophils are usually tissue-focused, the circulating count reflects both bone marrow output and how strongly immune signals are calling these cells into action.

Eosinophils support type 2 immune defenses by combating parasites and shaping allergic responses. They carry granules packed with potent effector molecules (major basic protein, eosinophil peroxidase), enzymes, and signaling cues (cytokines, lipid mediators) that can injure invaders, amplify inflammation, and promote tissue repair. They are guided by immune messengers such as IL-5 and eotaxins, migrating to irritated barrier surfaces to do their work. In plain terms, the eosinophil count serves as a window into Th2-skewed immune activity at body surfaces—showing how actively your immune system is engaging with triggers like allergens or parasites.

Where the count fits in body-wide immune signaling

Eosinophils are a type of white blood cell that patrols tissues in the lungs, skin, and gut, orchestrating allergic responses and defending against parasites. Because they release potent granules that can both fight invaders and inflame organs, their blood level is a window into "type 2" immunity and how the immune–endocrine system is behaving across the body.

Big picture: the eosinophil count connects immune activation to real-world organ effects and long-term risks like airway remodeling or cardiac fibrosis when elevations persist. Interpreted alongside the rest of the white cell differential, IgE, medications, travel history, and adrenal context, it helps pinpoint why inflammation is happening and where it may matter most.

Reading high, low, and in-range eosinophil counts

On a standard blood differential, eosinophils normally make up only a small single-digit percentage of white cells; many healthy adults sit at the low end of that range. Children often run slightly higher, while pregnancy tends to shift values lower. Low values usually reflect suppression of eosinophil release by stress hormones or corticosteroids (endogenous stress or prescribed steroids), a shift toward neutrophils during acute bacterial illness, or Cushing's syndrome. Pregnancy often lowers counts. True deficiency rarely causes symptoms and generally does not impair host defense. Very low results can occur with bone marrow suppression but are usually accompanied by other cytopenias. When the count is reduced, it usually reflects a surge of stress hormones (endogenous cortisol, epinephrine) from acute illness, surgery, or corticosteroid medicines, which transiently suppress or redistribute eosinophils. This state rarely causes symptoms by itself; it's more a marker of a systemic stress response than of an immune deficiency.

When the count is elevated, it signals activated type 2 immunity. Mild rises commonly track with allergies, eczema, nasal polyps, or asthma, bringing itch, wheeze, cough, and sinus issues. Higher or persistent elevations raise concern for parasitic infections, drug reactions, eosinophilic gastrointestinal disorders (abdominal pain, trouble swallowing), autoimmune conditions, adrenal insufficiency, or certain blood cancers. Very high levels can damage tissues—especially lungs, nerves, skin, and heart—via toxic granule proteins.

High values usually reflect allergic disease (asthma, rhinitis, eczema), drug hypersensitivity, parasitic helminth infections, eosinophilic gastrointestinal disorders, adrenal insufficiency (Addison's disease), certain autoimmune vasculitides (e.g., EGPA), or clonal bone marrow disorders. System effects include wheeze, rash, abdominal pain/diarrhea, and—when markedly elevated—risk of endomyocardial damage and thrombosis. Children more often show eosinophilia with atopy.

What can skew an eosinophil reading

Counts follow a daily rhythm (lowest in morning, higher at night). Glucocorticoids and anti–IL-5 biologics lower levels. Recent acute illness, age, pregnancy, and travel exposures affect interpretation. Consider absolute counts over percentages, which can be skewed by changes in total white cells or hydration.

Putting an eosinophil result to work

The eosinophils blood test measures how many eosinophils—a specialized white blood cell—are circulating, reported as an absolute count and/or percentage of white cells. Eosinophils reflect "type 2" immune activity that defends against parasites and helps with tissue repair, but also drives allergic inflammation in the airways, skin, and gut. Marked elevations can injure organs (heart, nerves, GI tract) through toxic granule release. Being in range suggests balanced type 2 immunity and stable barrier tissue function, with the capacity to respond to parasites and repair without excessive allergic inflammation. In healthy adults, values typically sit toward the lower end of the reference range and remain relatively stable over time.

FAQs

  • Eosinophils testing measures the number of eosinophils in your blood (absolute count and percentage) to assess allergic activity, parasitic exposure, drug hypersensitivity, and the overall pattern of immune-driven inflammation.
  • Testing helps clarify whether symptoms such as cough, wheeze, rashes, or abdominal pain are linked to allergic inflammation or other causes, and it tracks response to therapies like inhaled steroids or biologic medicines.
  • Frequency depends on your situation. Many people test during symptom changes, after starting or adjusting therapy, during known trigger seasons, and periodically to monitor trends.
  • Time of day, infections, medications (especially corticosteroids), physiological stress, allergic activity, parasitic infections, and recent travel or exposures can influence results.
  • Eosinophils are measured in a CBC with differential. Follow the collection instructions provided with your test; no special preparation is typically required.
  • Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

    We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

    References

    1. Klion, A. (2017). Recent advances in understanding eosinophil biology. F1000Research, 6, 1084. https://doi.org/10.12688/f1000research.11133.1
    2. Kuang, F. L. (2020). Approach to patients with eosinophilia. Medical Clinics of North America, 104(1), 1-14. https://doi.org/10.1016/j.mcna.2019.08.005
    3. El Brihi, J., & Pathak, S. (2024). Normal and abnormal complete blood count with differential. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK604207/
    4. Patil, S. U., & Shreffler, W. G. (2012). Immunology in the clinic review series; focus on allergies: Basophils as biomarkers for assessing immune modulation. Clinical and Experimental Immunology, 167(1), 59-66. https://doi.org/10.1111/j.1365-2249.2011.04503.x
    5. Islam, M. M., Satici, M. O., & Eroglu, S. E. (2024). Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: An extensive literature review. Turkish Journal of Emergency Medicine, 24(1), 8-19. https://doi.org/10.4103/tjem.tjem_198_23

    Built by the world’s top doctors and scientists

    Dr Anant Vinjamoori, MD

    Chief Longevity Officer, Superpower

    Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

    Learn more

    Dr Leigh Erin Connealy, MD

    Clinician & Founder of The Centre for New Medicine

    Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

    Learn more

    Dr Robert Lufkin

    UCLA Medical Professor, NYT Bestselling Author

    A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

    Learn more

    Dr Abe Malkin

    Founder & Medical Director of Concierge MD

    Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

    Learn more
    Membership slide 1
    Membership slide 1
    Membership slide 2
    Membership slide 3
    1 / 3

    Your membership starts here

    Annual 100+ biomarker panel

    Data dashboard and digital twin

    Upload past labs and connect wearables

    Personalized health protocol

    24/7 care team access

    AI companion for all health questions

    Marketplace with additional solutions

    $199

    /year*

    Billed annually

    HSA/ FSA eligible
    Cancel anytime
    Results in a week

    * Pricing may vary for members in New York and New Jersey